As the unusually cool summer on the west coast of North America starts to wind down, the Erowid crew is gearing up for the busier coming months. With the news of visionary artist Robert Venosa's death at 75 last week, we are again moved to remember the many elders in our field who have lead the way and the importance of trying to preserve their collected wisdom before it dissipates into the winds of passing years. Thanks to everyone who contributes to the evolution of knowledge about psychoactives.
In History...25 Years Ago Today
Twenty-five years ago, the psychoactive drug zeitgeist was dominated by the crack-cocaine scourge, a control controversy around MDMA, and the growing issue of "designer drugs". In May 1986, an administrative judge ruled that the DEA's adding of MDMA to Schedule I was invalid, triggering legal battles. In June, at the height of the Reagan-era crack cocaine explosion, basketball player Len Bias's cocaine-related death was a major media event. In August 1986, Discover magazine published "Beyond Crack: The Growing Peril of Designer Drugs" and Good Housekeeping published "Crack: Dangerous New Drug".
Earth and Fire will be speaking at the Entheogenesis Australis Conference (Dec 2 - 5, 2011)
north of Melbourne, Australia. Come join us at this three-day outdoor event!
In July, the DEA published a Federal Register (FR) entry denying a petition to reschedule cannabis. Curiously, there are two distinct voices in the publication, one from the Department of Health and Human Services (DHHS) and one from the DEA. This FR entry includes discussion of the linkage between cannabis use and psychosis, with the DHHS stating "At present, the data do not suggest a causative link between marijuana use and the development of psychosis." Later in the entry, the DEA rebuts this, arguing that evidence does show a causal connection. An amusing (yet disturbing) dispute between the scientific body (the DHHS) and the political/police body (the DEA).
Another interesting point about this document is it appears to offer a formalized view by both DHHS and the DEA that cannabis is not a "gateway drug".
From the Vaults
More New Content
(see 140 new)
(see 23 new results)
EcstasyData is a project of Erowid Center that conducts laboratory testing of street Ecstasy tablets and publishes these and other test results online.
Donate Or Become A Member
List Subscription Information